| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |